{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:33:08Z","timestamp":1791916388839,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"S7","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.31560317"],"award-info":[{"award-number":["No.31560317"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.61972185"],"award-info":[{"award-number":["No.61972185"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Yunnan Ten Thousand Talents Plan young","award":["2019"],"award-info":[{"award-number":["2019"]}]},{"name":"Natural Science Foundation of Yunnan Province of China","award":["2019FA024"],"award-info":[{"award-number":["2019FA024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cancer as a kind of genomic alteration disease each year deprives many people\u2019s life. The biggest challenge to overcome cancer is to identify driver genes that promote the cancer development from a huge amount of passenger mutations that have no effect on the selective growth advantage of cancer. In order to solve those problems, some researchers have started to focus on identification of driver genes by integrating networks with other biological information. However, more efforts should be needed to improve the prediction performance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Considering the facts that driver genes have impact on expression of their downstream genes, they likely interact with each other to form functional modules and those modules should tend to be expressed similarly in the same tissue. We proposed a novel model named by DyTidriver to identify driver genes through involving the gene dysregulated expression, tissue-specific expression and variation frequency into the human functional interaction network (e.g. human FIN).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This method was applied on 974 breast, 316 prostate and 230 lung cancer patients. The consequence shows our method outperformed other five existing methods in terms of Fscore, Precision and Recall values. The enrichment and cociter analysis illustrate DyTidriver can not only identifies the driver genes enriched in some significant pathways but also has the capability to figure out some unknown driver genes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The final results imply that driver genes are those that impact more dysregulated genes and express similarly in the same tissue.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-019-0619-z","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T07:02:20Z","timestamp":1577689340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Identifying driver genes involving gene dysregulated expression, tissue-specific expression and gene-gene network"],"prefix":"10.1186","volume":"12","author":[{"given":"Junrong","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9572-951X","authenticated-orcid":false,"given":"Wei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"issue":"1","key":"619_CR1","first-page":"3","volume":"1","author":"SG Baker","year":"2017","unstructured":"Baker SG. The questionable premises underlying the search for cancer driver mutations and cancer susceptibility genes. Organisms Journal of Biological Sciences. 2017;1(1):3\u20134.","journal-title":"Organisms Journal of Biological Sciences"},{"key":"619_CR2","doi-asserted-by":"crossref","unstructured":"Kumar S, Warrel J, Mcgillivray P, Meyerson W, Li S, Salichos L, et al. Passenger mutation landscape in cancer genomes. AACR. 2018:1279\u20139.","DOI":"10.1158\/1538-7445.AM2018-1279"},{"issue":"11","key":"619_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrg3317","volume":"13","author":"LR Yates","year":"2012","unstructured":"Yates LR, Campbell PJ. Evolution of the cancer genome. Nat Rev Genet. 2012;13(11):795.","journal-title":"Nat Rev Genet"},{"issue":"9","key":"619_CR4","doi-asserted-by":"publisher","first-page":"e1007381","DOI":"10.1371\/journal.pcbi.1007381","volume":"15","author":"O Collier","year":"2019","unstructured":"Collier O, Stoven V, Vert J-P. LOTUS: a single-and multitask machine learning algorithm for the prediction of cancer driver genes. PLoS Comput Biol. 2019;15(9):e1007381.","journal-title":"PLoS Comput Biol"},{"issue":"7132","key":"619_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature05610","volume":"446","author":"C Greenman","year":"2007","unstructured":"Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446(7132):153.","journal-title":"Nature."},{"issue":"7216","key":"619_CR6","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Network CGAR","year":"2008","unstructured":"Network CGAR. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061.","journal-title":"Nature."},{"issue":"7291","key":"619_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature08987","volume":"464","author":"ICG Consortium","year":"2010","unstructured":"Consortium ICG. International network of cancer genome projects. Nature. 2010;464(7291):993.","journal-title":"Nature."},{"issue":"7239","key":"619_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458(7239):719.","journal-title":"Nature."},{"key":"619_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-pathol-012414-040312","volume":"10","author":"JR Pon","year":"2015","unstructured":"Pon JR, Marra MA. Driver and passenger mutations in cancer. Annual Review of Pathology: Mechanisms of Disease. 2015;10:25\u201350.","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"issue":"7471","key":"619_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502(7471):333.","journal-title":"Nature."},{"issue":"6127","key":"619_CR11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546\u201358.","journal-title":"Science"},{"issue":"7645","key":"619_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature21386","volume":"543","author":"CGAR Network","year":"2017","unstructured":"Network CGAR. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378.","journal-title":"Nature."},{"issue":"7216","key":"619_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature07423","volume":"455","author":"L Ding","year":"2008","unstructured":"Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008;455(7216):1069.","journal-title":"Nature."},{"issue":"7360","key":"619_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011;476(7360):298.","journal-title":"Nature."},{"issue":"5676","key":"619_CR15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, J\u00e4nne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304(5676):1497\u2013500.","journal-title":"Science."},{"issue":"4987","key":"619_CR16","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/science.2274789","volume":"250","author":"P-L Chen","year":"1990","unstructured":"Chen P-L, Chen Y, Bookstein R, Lee W-H. Genetic mechanisms of tumor suppression by the human p53 gene. Science. 1990;250(4987):1576\u201380.","journal-title":"Science."},{"issue":"2","key":"619_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0090-8258(03)00264-6","volume":"90","author":"ML Gemignani","year":"2003","unstructured":"Gemignani ML, Schlaerth AC, Faina B, Barakat RR, Oscar L, Robert S, et al. Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma. Gynecol Oncol. 2003;90(2):378\u201381.","journal-title":"Gynecol Oncol"},{"issue":"5994","key":"619_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/312513a0","volume":"312","author":"AL Schechter","year":"1984","unstructured":"Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, et al. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature. 1984;312(5994):513.","journal-title":"Nature."},{"key":"619_CR19","doi-asserted-by":"crossref","unstructured":"Reimand J. Candidate non-coding driver mutations in super-enhancers and long-range chromatin interaction networks across 1,800 whole cancer genomes. AACR. 2018:2354\u20134.","DOI":"10.1158\/1538-7445.AM2018-2354"},{"issue":"7457","key":"619_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214.","journal-title":"Nature."},{"issue":"7403","key":"619_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature11154","volume":"486","author":"S Banerji","year":"2012","unstructured":"Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012;486(7403):405.","journal-title":"Nature."},{"issue":"8","key":"619_CR22","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1101\/gr.134635.111","volume":"22","author":"ND Dees","year":"2012","unstructured":"Dees ND, Zhang Q, Kandoth C, Wendl MC, Schierding W, Koboldt DC, et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 2012;22(8):1589.","journal-title":"Genome Res"},{"issue":"4","key":"619_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/bib\/bbv068","volume":"17","author":"F Cheng","year":"2015","unstructured":"Cheng F, Zhao J, Zhao Z. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes. Brief Bioinform. 2015;17(4):642\u201356.","journal-title":"Brief Bioinform"},{"issue":"17","key":"619_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12859-016-1332-y","volume":"17","author":"P-J Wei","year":"2016","unstructured":"Wei P-J, Zhang D, Xia J, Zheng C-H. LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network. BMC bioinformatics. 2016;17(17):467.","journal-title":"BMC bioinformatics"},{"issue":"3","key":"619_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/cmb.2010.0265","volume":"18","author":"F Vandin","year":"2011","unstructured":"Vandin F, Upfal E, Raphael BJ. Algorithms for detecting significantly mutated pathways in cancer. J Comput Biol. 2011;18(3):507\u201322.","journal-title":"J Comput Biol"},{"issue":"2","key":"619_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng.3168","volume":"47","author":"MD Leiserson","year":"2015","unstructured":"Leiserson MD, Vandin F, Wu H-T, Dobson JR, Eldridge JV, Thomas JL, et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet. 2015;47(2):106.","journal-title":"Nat Genet"},{"issue":"11","key":"619_CR27","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nmeth.2651","volume":"10","author":"M Hofree","year":"2013","unstructured":"Hofree M, Shen JP, Carter H, Gross A, Ideker T. Network-based stratification of tumor mutations. Nat Methods. 2013;10(11):1108.","journal-title":"Nat Methods"},{"issue":"1","key":"619_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13059-016-0989-x","volume":"17","author":"A Cho","year":"2016","unstructured":"Cho A, Shim JE, Kim E, Supek F, Lehner B, Lee I. MUFFINN: cancer gene discovery via network analysis of somatic mutation data. Genome Biol. 2016;17(1):129.","journal-title":"Genome Biol"},{"issue":"12","key":"619_CR29","doi-asserted-by":"publisher","first-page":"R124","DOI":"10.1186\/gb-2012-13-12-r124","volume":"13","author":"A Bashashati","year":"2012","unstructured":"Bashashati A, Haffari G, Ding J, Ha G, Lui K, Rosner J, et al. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer. Genome Biol. 2012;13(12):R124.","journal-title":"Genome Biol"},{"issue":"9","key":"619_CR30","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1039\/C6MB00274A","volume":"12","author":"K Shi","year":"2016","unstructured":"Shi K, Gao L, Wang B. Discovering potential cancer driver genes by an integrated network-based approach. Mol BioSyst. 2016;12(9):2921\u201331.","journal-title":"Mol BioSyst"},{"issue":"7","key":"619_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13073-014-0056-8","volume":"6","author":"JP Hou","year":"2014","unstructured":"Hou JP, Ma J. DawnRank: discovering personalized driver genes in cancer. Genome medicine. 2014;6(7):56.","journal-title":"Genome medicine"},{"issue":"11","key":"619_CR32","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/bioinformatics\/bty006","volume":"34","author":"W-F Guo","year":"2018","unstructured":"Guo W-F, Zhang S-W, Liu L-L, Liu F, Shi Q-Q, Zhang L, et al. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy. Bioinformatics. 2018;34(11):1893\u2013903.","journal-title":"Bioinformatics."},{"issue":"3","key":"619_CR33","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1752-0509-8-S3-S3","volume":"8","author":"GU Ganegoda","year":"2014","unstructured":"Ganegoda GU, Wang J, Wu F-X, Li M. Prediction of disease genes using tissue-specified gene-gene network. BMC Syst Biol. 2014;8(3):S3.","journal-title":"BMC Syst Biol"},{"issue":"52","key":"619_CR34","doi-asserted-by":"publisher","first-page":"20870","DOI":"10.1073\/pnas.0810772105","volume":"105","author":"K Lage","year":"2008","unstructured":"Lage K, Hansen NT, Karlberg EO, Eklund AC, Roque FS, Donahoe PK, et al. A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci. 2008;105(52):20870\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"619_CR35","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/gb-2010-11-5-r53","volume":"11","author":"G Wu","year":"2010","unstructured":"Wu G, Feng X, Stein L. A human functional protein interaction network and its application to cancer data analysis. Genome Biol. 2010;11(5):R53.","journal-title":"Genome Biol"},{"issue":"3","key":"619_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, et al. A census of human cancer genes. Nat Rev Cancer. 2004;4(3):177.","journal-title":"Nat Rev Cancer"},{"key":"619_CR37","doi-asserted-by":"crossref","unstructured":"An O, Pendino V, D\u2019Antonio M, Ratti E, Gentilini M, Ciccarelli FD: NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes. Database. 2014;2014.","DOI":"10.1093\/database\/bau015"},{"issue":"3","key":"619_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1109\/TCBB.2010.75","volume":"8","author":"J Wang","year":"2011","unstructured":"Wang J, Li M, Chen J, Pan Y. A fast hierarchical clustering algorithm for functional modules discovery in protein interaction networks. IEEE\/ACM Transactions on Computational Biology and Bioinformatics (TCBB). 2011;8(3):607\u201320.","journal-title":"IEEE\/ACM Transactions on Computational Biology and Bioinformatics (TCBB)"},{"issue":"2","key":"619_CR39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1109\/TCBB.2015.2394314","volume":"14","author":"W Peng","year":"2017","unstructured":"Peng W, Li M, Chen L, Wang L. Predicting protein functions by using unbalanced random walk algorithm on three biological networks. IEEE\/ACM transactions on computational biology and bioinformatics. 2017;14(2):360\u20139.","journal-title":"IEEE\/ACM transactions on computational biology and bioinformatics"},{"issue":"1","key":"619_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1109\/TCBB.2014.2343954","volume":"12","author":"W Peng","year":"2015","unstructured":"Peng W, Wang J, Zhao B, Wang L. Identification of protein complexes using weighted PageRank-nibble algorithm and core-attachment structure. IEEE\/ACM Transactions on Computational Biology and Bioinformatics (TCBB). 2015;12(1):179\u201392.","journal-title":"IEEE\/ACM Transactions on Computational Biology and Bioinformatics (TCBB)"},{"key":"619_CR41","doi-asserted-by":"publisher","unstructured":"Song J, Peng W, Wang F: An Entropy-based method for identifying mutual exclusive driver genes in cancer. IEEE\/ACM transactions on computational biology and bioinformatics. 2019.2.7;https:\/\/doi.org\/10.1109\/TCBB.","DOI":"10.1109\/TCBB"},{"issue":"1","key":"619_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2008","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2008;4(1):44.","journal-title":"Nat Protoc"},{"issue":"8","key":"619_CR43","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1158\/1535-7163.MCT-12-1019","volume":"12","author":"S Rajput","year":"2013","unstructured":"Rajput S, Volk-Draper LD, Ran S. TLR4 is a novel determinant of the response to paclitaxel in breast cancer. Mol Cancer Ther. 2013;12(8):1676\u201387.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"619_CR44","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1210\/jc.2010-1071","volume":"96","author":"MH Lee","year":"2011","unstructured":"Lee MH, Lee SE, Kim DW, Ryu MJ, Kim SJ, Kim SJ, et al. Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E. The Journal of Clinical Endocrinology & Metabolism. 2011;96(1):E19\u201330.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"619_CR45","doi-asserted-by":"publisher","first-page":"e53476","DOI":"10.1371\/journal.pone.0053476","volume":"8","author":"MK Kwak","year":"2013","unstructured":"Kwak MK, Johnson DT, Zhu C, Lee SH, Ye D-W, Luong R, et al. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors. PLoS One. 2013;8(1):e53476.","journal-title":"PLoS One"},{"issue":"10","key":"619_CR46","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.bbamcr.2006.08.026","volume":"1763","author":"C Fan","year":"2006","unstructured":"Fan C, Quan R, Feng X, Gillis A, He L, Matsumoto ED, et al. ATM activation is accompanied with earlier stages of prostate tumorigenesis. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2006;1763(10):1090\u20137.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"issue":"2","key":"619_CR47","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ajpath.2011.10.021","volume":"180","author":"J Gerhardt","year":"2012","unstructured":"Gerhardt J, Montani M, Wild P, Beer M, Huber F, Hermanns T, et al. FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer. Am J Pathol. 2012;180(2):848\u201361.","journal-title":"Am J Pathol"},{"issue":"5","key":"619_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jmoldx.2015.04.003","volume":"17","author":"W Wen","year":"2015","unstructured":"Wen W, Xiao N, Bender R, Ghazalpour A, Tan Z, Swensen J, et al. Mutations in the kinase domain of the HER2\/ERBB2 gene identified in a wide variety of human cancers. The Journal of Molecular Diagnostics. 2015;17(5):487\u201395.","journal-title":"The Journal of Molecular Diagnostics"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-019-0619-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-019-0619-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-019-0619-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:09:42Z","timestamp":1609200582000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-019-0619-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":48,"journal-issue":{"issue":"S7","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1186\/s12920-019-0619-z","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}